Work

Key Challenges on the Path toward Precision Immunotherapy for Large B-cell Lymphoma

Year: 2026

Type: article

Abstract: Cell and immune therapies have transformed the outcomes of patients with lymphoma, but the majority of patients do not have durable benefit. Here, we provide our perspective on key challenges in personalizing cell and immune therapy approaches for lymphoma through discovery, validation, and clinical deployment of microenvironment classification.

Source: Blood Cancer Discovery

DOI: 10.1158/2643-3230.bcd-26-0357

Authors: Xubin Li, Christopher R. Flowers, Michael R. Green

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W7223281142